Literature DB >> 24808180

Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein.

Ilker Karaca1, Irfan Y Tamboli1, Konstantin Glebov1, Josefine Richter2, Lisa H Fell3, Marcus O Grimm3, Viola J Haupenthal3, Tobias Hartmann3, Markus H Gräler4, Gerhild van Echten-Deckert5, Jochen Walter6.   

Abstract

Progressive accumulation of the amyloid β protein in extracellular plaques is a neuropathological hallmark of Alzheimer disease. Amyloid β is generated during sequential cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. In addition to the proteolytic processing by secretases, APP is also metabolized by lysosomal proteases. Here, we show that accumulation of intracellular sphingosine-1-phosphate (S1P) impairs the metabolism of APP. Cells lacking functional S1P-lyase, which degrades intracellular S1P, strongly accumulate full-length APP and its potentially amyloidogenic C-terminal fragments (CTFs) as compared with cells expressing the functional enzyme. By cell biological and biochemical methods, we demonstrate that intracellular inhibition of S1P-lyase impairs the degradation of APP and CTFs in lysosomal compartments and also decreases the activity of γ-secretase. Interestingly, the strong accumulation of APP and CTFs in S1P-lyase-deficient cells was reversed by selective mobilization of Ca(2+) from the endoplasmic reticulum or lysosomes. Intracellular accumulation of S1P also impairs maturation of cathepsin D and degradation of Lamp-2, indicating a general impairment of lysosomal activity. Together, these data demonstrate that S1P-lyase plays a critical role in the regulation of lysosomal activity and the metabolism of APP.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Alzheimer Disease; Amyloid; Amyloid Precursor Protein (APP); Lysosome; Sphingolipid; Sphingosine-1-phosphate (S1P)

Mesh:

Substances:

Year:  2014        PMID: 24808180      PMCID: PMC4059120          DOI: 10.1074/jbc.M113.535500

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Identification and biology of β-secretase.

Authors:  Patty C Kandalepas; Robert Vassar
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

2.  Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.

Authors:  R Yan; M J Bienkowski; M E Shuck; H Miao; M C Tory; A M Pauley; J R Brashier; N C Stratman; W R Mathews; A E Buhl; D B Carter; A G Tomasselli; L A Parodi; R L Heinrikson; M E Gurney
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

3.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

4.  Generation of Alzheimer disease-associated amyloid β42/43 peptide by γ-secretase can be inhibited directly by modulation of membrane thickness.

Authors:  Edith Winkler; Frits Kamp; Johannes Scheuring; Amelie Ebke; Akio Fukumori; Harald Steiner
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

Review 5.  Biological and diagnostic role of cathepsin D.

Authors:  A Bańkowska; M Gacko; E Chyczewska; A Worowska
Journal:  Rocz Akad Med Bialymst       Date:  1997

Review 6.  Linking lipids to Alzheimer's disease: cholesterol and beyond.

Authors:  Gilbert Di Paolo; Tae-Wan Kim
Journal:  Nat Rev Neurosci       Date:  2011-03-30       Impact factor: 34.870

7.  Cholesterol-depletion corrects APP and BACE1 misstrafficking in NPC1-deficient cells.

Authors:  Martina Malnar; Marko Kosicek; Ana Lisica; Melanija Posavec; Ana Krolo; Jasenka Njavro; Damir Omerbasic; Sabina Tahirovic; Silva Hecimovic
Journal:  Biochim Biophys Acta       Date:  2012-04-19

8.  Sphingolipid storage impairs autophagic clearance of Alzheimer-associated proteins.

Authors:  Irfan Y Tamboli; Nguyen T Tien; Jochen Walter
Journal:  Autophagy       Date:  2011-06-01       Impact factor: 16.016

9.  Quantification of sphingosine-1-phosphate and related sphingolipids by liquid chromatography coupled to tandem mass spectrometry.

Authors:  Constantin Bode; Markus H Gräler
Journal:  Methods Mol Biol       Date:  2012

Review 10.  Amyloid precursor protein trafficking, processing, and function.

Authors:  Gopal Thinakaran; Edward H Koo
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

View more
  25 in total

Review 1.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.

Authors:  Marcus O W Grimm; Daniel M Michaelson; Tobias Hartmann
Journal:  J Lipid Res       Date:  2017-05-20       Impact factor: 5.922

Review 2.  Cellular cholesterol homeostasis and Alzheimer's disease.

Authors:  Ta-Yuan Chang; Yoshio Yamauchi; Mazahir T Hasan; Catherine Chang
Journal:  J Lipid Res       Date:  2017-03-15       Impact factor: 5.922

3.  Upregulation of ABC transporters contributes to chemoresistance of sphingosine 1-phosphate lyase-deficient fibroblasts.

Authors:  Katja Ihlefeld; Hans Vienken; Ralf Frederik Claas; Kira Blankenbach; Agnes Rudowski; Michael ter Braak; Alexander Koch; Paul P Van Veldhoven; Josef Pfeilschifter; Dagmar Meyer zu Heringdorf
Journal:  J Lipid Res       Date:  2014-11-10       Impact factor: 5.922

Review 4.  Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.

Authors:  Efthalia Angelopoulou; Christina Piperi
Journal:  Neuromolecular Med       Date:  2019-07-16       Impact factor: 3.843

5.  Sphingosine-1-phosphate-lyase deficiency affects glucose metabolism in a way that abets oncogenesis.

Authors:  Sumaiya Y Afsar; Shah Alam; Carina Fernandez Gonzalez; Gerhild van Echten-Deckert
Journal:  Mol Oncol       Date:  2022-08-16       Impact factor: 7.449

6.  Trehalose Alters Subcellular Trafficking and the Metabolism of the Alzheimer-associated Amyloid Precursor Protein.

Authors:  Nguyen T Tien; Ilker Karaca; Irfan Y Tamboli; Jochen Walter
Journal:  J Biol Chem       Date:  2016-03-08       Impact factor: 5.157

7.  Cyclopamine modulates γ-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation.

Authors:  Anna G Vorobyeva; Randall Lee; Sean Miller; Charles Longen; Michal Sharoni; Preeti J Kandelwal; Felix J Kim; Daniel R Marenda; Aleister J Saunders
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

8.  Deficiency of Neuronal p38α MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1.

Authors:  Laura Schnöder; Wenlin Hao; Yiren Qin; Shirong Liu; Inge Tomic; Xu Liu; Klaus Fassbender; Yang Liu
Journal:  J Biol Chem       Date:  2015-12-09       Impact factor: 5.157

Review 9.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 10.  Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2.

Authors:  Emma J Arsenault; Colin M McGill; Brian M Barth
Journal:  Neuromolecular Med       Date:  2021-02-05       Impact factor: 4.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.